Yesterday's press release from the company states that it has had success in its two double-blind trials and that it will file for FDA approval in the 4th quarter of 2011. This implies that approval will probably not be granted until late 2012.

Please contact the company and request that they extend the open label study until FDA approval is received.

Thanks again for your help.